Anixa Biosciences to Participate in the 2022 Virtual Growth Conference Hosted by M-Vest, a Division of Maxim Group LLC

SAN JOSE, Calif., March 17, 2022 /PRNewswire/ -- Anixa Biosciences, Inc. , a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced today that the... | March 17, 2022

Related Keywords

Eric Ribner ,Mike Catelani ,Prnewswire Anixa Biosciences Inc ,Anixa Biosciences Inc ,Maxim Group ,Lifesci Communications ,Lifesci Advisors ,Company Contact ,Nasdaq ,Growth Conference ,Chief Operating Officer ,Chief Financial Officer ,Anixa Biosciences ,Operating Officer ,Chief Financial ,Salve Nissan ,Sci Advisors ,Nc Stock Exchange ,News ,Information ,Press Release ,Han ,Arch ,022 ,Anixa ,Biotechnology ,Company ,Ocused ,N ,The ,Treatment ,End ,Prevention ,F ,Dancer ,Nfectious ,Nnounced ,Oday ,Hat Anix Us03528h1095 ,